{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T09:27:13Z","timestamp":1794562033483,"version":"4.9.1"},"reference-count":0,"publisher":"HCA Healthcare","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["HCA Healthcare Journal of Medicine"],"abstract":"<jats:p>Background \nVaccinations for COVID-19 have played a pivotal role in controlling the global pandemic, with most adverse events being mild and transient. However, rare post-vaccination autoimmune responses have been reported. The understanding of long-term rheumatologic sequelae, particularly autoimmune polyarthritis following COVID-19 vaccination, remains limited.\nCase Presentation \nWe report the case of a 41-year-old previously healthy man who developed progressive polyarthritis and systemic symptoms following the Johnson &amp; Johnson COVID-19 vaccine. The initial symptoms of joint swelling and arthralgia appeared within a week of the first vaccine dose, subsiding temporarily with medication. After receiving a booster dose, the patient experienced worsening polyarthritis affecting multiple joints including knees, elbows, wrists, shoulders, and neck, along with low-grade fever, fatigue, and functional decline. Despite outpatient anti-inflammatory therapy, symptoms persisted and worsened over the next six months, prompting hospitalization. Workup revealed elevated inflammatory markers (ESR 77 mm\/hr, CRP 193.2 mg\/L), synovial fluid consistent with inflammatory arthritis, and infectious serologies. Imaging showed joint effusions and calcified pulmonary granulomas. He was diagnosed with vaccine-induced reactive arthritis. Treatment with intravenous corticosteroids led to partial symptom relief, and he was discharged on oral steroids and initiated on methotrexate for long-term management.\nConclusion \nClinicians should maintain a high index of suspicion for autoimmune phenomena such as reactive polyarthritis following COVID-19 vaccination, especially in patients with new-onset joint symptoms. Early recognition and referral to rheumatology may improve outcomes. Further studies are needed to clarify the pathophysiology, risk factors, and long-term prognosis of such vaccine-associated autoimmune conditions.<\/jats:p>","DOI":"10.36518\/2689-0216.1619","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T17:54:07Z","timestamp":1751392447000},"source":"Crossref","is-referenced-by-count":0,"title":["Long-Term Autoimmune Polyarthritis due to COVID-19 Vaccine"],"prefix":"10.36518","volume":"6","author":[{"given":"Ramesh","family":"Pandit","sequence":"first","affiliation":[{"name":"University of Pennsylvania, West Chester, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namratha","family":"Pallipamu","sequence":"additional","affiliation":[{"name":"Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trupiti","family":"Pandit","sequence":"additional","affiliation":[{"name":"ChristianaCare, Wilmington, Delaware"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"22435","published-online":{"date-parts":[[2025,6,30]]},"container-title":["HCA Healthcare Journal of Medicine"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T08:47:53Z","timestamp":1794559673000},"score":1,"resource":{"primary":{"URL":"https:\/\/scholarlycommons.hcahealthcare.com\/hcahealthcarejournal\/vol6\/iss3\/8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,30]]},"references-count":0,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,6,30]]}},"URL":"https:\/\/doi.org\/10.36518\/2689-0216.1619","relation":{},"ISSN":["2689-0216"],"issn-type":[{"value":"2689-0216","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,30]]}}}